NEUP · Forms 3, 4, 5
Insider trades at Neuphoria Therapeutics Inc.
No open-market insider buys or sells at Neuphoria Therapeutics Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Neuphoria Therapeutics Inc. (NEUP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Neuphoria Therapeutics Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| David Ian Wilson | Director | Options or other derivatives | Form 4 | ||||
| Peter Miles Winston Davies | Director | Options or other derivatives | Form 4 | ||||
| Alan Fisher | Director | Options or other derivatives | Form 4 | ||||
| Jane Ryan | Director | Options or other derivatives | Form 4 | ||||
| Lynx1 Capital Management LP | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Lynx1 Capital Management LP | 10% owner | Buy | 639,110 | $5.14 | $3.3M | Form 4 | |
| Spyros Papapetropoulos | President and CEO | Options or other derivatives | Form 4 | ||||
| Spyros Papapetropoulos | President and CEO | Options or other derivatives | Form 4 | ||||
| Peter Miles Winston Davies | Director | Options or other derivatives | Form 4 | ||||
| Jane Ryan | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.